Logomasini Mark 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 20, 2013
Insider Transaction Report
Form 4
Logomasini Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2013-02-15+2,000,000→ 2,045,000 totalExercise: $0.06Exp: 2023-02-14→ BJCT Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]Vesting Schedule: 1/3 Annually Commencing 2/15/14